Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers - Wikidata - awgldk - TriplyDB

Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers

Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers

http://www.wikidata.org/entity/Q34033258

about

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers.Beyond PSA: the next generation of prostate cancer biomarkers.Human urine proteomics: building a list of human urine cancer biomarkers.Biomarkers for the diagnosis of new and recurrent prostate cancer.Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis.Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy.Clinical applications of MS-based protein quantification.Protein biomarker quantification by mass spectrometry.High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease.Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.

P2860

Q21134794-D4C6BB02-44D9-49CE-AD08-2A889A8958AF Q33514542-DCA3D359-D615-4DB7-9984-318F02880DE6 Q33567004-9923CE29-C2A1-4D2A-896D-D102CBFDAE75 Q36556482-45388D41-398E-4C50-B763-50F9903EC684 Q37238101-71D3D8E0-66DE-42B1-8FBE-B5502E4E7772 Q37890422-254822CB-05F9-4068-A80B-E00688E9776F Q38052926-FECD4B9F-0C40-4556-8D9B-CD4267C1A2A5 Q38409373-1466B0FD-FD8E-405F-B928-2A96F9B5B56A Q38502644-F730AEEE-C10B-46E1-B11F-BBBB6BF18B1E Q38802991-2CCC070B-0A5E-45EA-9F6E-686100109E5F Q39913983-5FF13274-D1EF-4BF2-8CE6-481CC952B2A3 Q44956259-F78686B5-FACE-4C96-96C6-642C15E730D0 Q47100267-3E09FFBE-9B0F-4FF3-B8BB-A8B5BEE0EA0C

P2860

Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers

http://www.wikidata.org/entity/Q34033258

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@ast

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@en

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@nl

type

label

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@ast

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@en

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@nl

prefLabel

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@ast

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@en

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@nl

P1433

Q34033258-41F90575-AC30-4EAA-AF0C-CE80DC6F0AD5

P1476

Q34033258-083FF69D-754C-409D-95C6-C590D7038F35

P2093

Q34033258-1E4EBEB5-AE88-4994-88BA-E4A1A9EF1140

Q34033258-22E69954-9139-4661-A537-A36D38F09302

Q34033258-300466D8-5275-45B8-9153-002F7C687FD4

Q34033258-741291CA-B5A4-40B6-8FA4-0485C6F26838

Q34033258-824F45D5-2FDD-450F-B2A0-D0DB32D16193

Q34033258-EEE57D8C-2312-4D5F-AFFE-13D57464D219

P2860

Q34033258-08C452C3-9DCF-4D63-B76E-40A493FCA45F

Q34033258-0C24A6B5-AC95-43A6-AA3A-A8D39C588C51

Q34033258-4B482920-8A7F-45D8-9BB6-BD003823D220

Q34033258-53AEFDF3-A76C-42A2-80E4-3CAB50C0E65B

Q34033258-610373F5-5570-44B6-8271-744E60D0F421

Q34033258-8787D6C0-F4B7-41BF-BB31-5FBB933799CC

Q34033258-89041092-3A81-4490-B02C-B4933BE33065

Q34033258-8C7103E9-7C67-4970-B4AC-6A1050817DA8

Q34033258-A98E7290-A9A2-497F-8DA0-19D0F9645FE2

Q34033258-C7C7C1A1-CE27-4C2C-BEBF-118F7A4D03E1

P304

Q34033258-4973E46A-2981-414A-A82A-8E54EC66A415

P31

Q34033258-3E21D2C4-6E65-442B-973B-49FBBADCFF70

P356

Q34033258-40C3949F-BDAE-49C7-853C-017D68E31D50

P407

Q34033258-75B05F6D-E28E-44C2-9419-A3EBCC012173

P433

Q34033258-E9831796-9048-4818-A918-0F3F8197E487

P478

Q34033258-E105F39A-E149-4254-B98A-18F123387105

P50

Q34033258-54822EA1-D4B1-4CAE-AF86-29F28B0816AC

P577

Q34033258-E633BAB1-98C7-4AC2-AEBF-BBAF1AE5EFEE

P698

Q34033258-6B7BBBFD-7356-47AB-8F18-28AC7353E172

P921

Q34033258-83C2FB74-84D3-4B6A-A746-073A43B2469E

P932

Q34033258-73D29BA7-85EE-4059-81B5-14246C854059

P356

J.JURO.2008.10.142

P1433

The Journal of Urology

P1476

Predicting prostate cancer bio ...... of serum proteomic biomarkers

@en

P2093

C Nicole Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Daniel W Chan

http://www.w3.org/2001/XMLSchema#string

Katherine Osborne

http://www.w3.org/2001/XMLSchema#string

Lori J Sokoll

http://www.w3.org/2001/XMLSchema#string

Xiaer Sun

http://www.w3.org/2001/XMLSchema#string

Zhen Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.

Differential exoprotease activities confer tumor-specific serum peptidome patterns

Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.

Analysis of specific proteins in prostatic fluid for detecting prostatic malignancy.

Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues.

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

P304

1407-1414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2008.10.142

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19157448

http://www.w3.org/2001/XMLSchema#string

P921

P932

4130150

http://www.w3.org/2001/XMLSchema#string